APPLICATION
NDA218710
TYPE
NDA
ORIGINAL APPROVAL
2024-07-17
LATEST ACTION
2024-07-17
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
VOQUEZNAPrescription
VONOPRAZAN FUMARATE EQ 10MG BASE · TABLET · ORAL
VOQUEZNAPrescription
VONOPRAZAN FUMARATE EQ 20MG BASE · TABLET · ORAL
Approval history
2024-07-17Type 9 - New Indication Submitted as Distinct NDA, Consolidated with Original NDA after Approval · Original · standard — Letter ↗AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.